Stock Analysts’ Updated EPS Estimates for September, 6th (BCRX, BKNIY, CHKE, CLBS, CM, CME, COUP, CSCO, DAL, DD)

Stock Analysts’ updated eps estimates for Wednesday, September 6th:

BioCryst Pharmaceuticals (NASDAQ:BCRX) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $10.00 price target on the stock.

Bankinter SA (OTC:BKNIY) was upgraded by analysts at Goldman Sachs Group, Inc. (The) from a sell rating to a neutral rating.

Cherokee (NASDAQ:CHKE) had its buy rating reissued by analysts at FBR & Co. The firm currently has a $8.00 price target on the stock.

Caladrius Biosciences (NASDAQ:CLBS) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $7.00 target price on the stock.

Canadian Imperial Bank of Commerce (TSE:CM) (NYSE:CM) was upgraded by analysts at TD Securities from a hold rating to a buy rating. They currently have C$120.00 price target on the stock.

CME Group (NASDAQ:CME) had its buy rating reiterated by analysts at UBS AG. They currently have a $135.00 target price on the stock, up from their previous target price of $134.00.

Coupa Software (NASDAQ:COUP) had its buy rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $36.00 price target on the stock.

Cisco Systems (NASDAQ:CSCO) had its buy rating reaffirmed by analysts at Deutsche Bank AG. They currently have a $40.00 price target on the stock.

Dalata Hotel Group Plc (LON:DAL) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 525 ($6.78) price target on the stock.

E I Du Pont De Nemours And (NYSE:DD) had its buy rating reaffirmed by analysts at Morgan Stanley. They currently have a $77.00 price target on the stock.

Facebook (NASDAQ:FB) had its sell rating reissued by analysts at Pivotal Research. Pivotal Research currently has a $140.00 target price on the stock.

First Quantum Minerals Limited (TSE:FM) was upgraded by analysts at BNP Paribas from an underperform rating to a neutral rating.

Canada Goose Holdings (NYSE:GOOS) had its buy rating reaffirmed by analysts at Canaccord Genuity. Canaccord Genuity currently has a $34.00 price target on the stock.

Hewlett Packard Enterprise (NYSE:HPE) had its hold rating reissued by analysts at Robert W. Baird.

HealthEquity (NASDAQ:HQY) had its buy rating reissued by analysts at Oppenheimer Holdings, Inc.. Oppenheimer Holdings, Inc. currently has a $61.00 price target on the stock.

Macy’s (NYSE:M) had its market perform rating reissued by analysts at Cowen and Company. The firm currently has a $23.00 target price on the stock.

MGM Growth Properties (NYSE:MGP) had its buy rating reissued by analysts at UBS AG. The firm currently has a $33.00 price target on the stock, up from their previous price target of $30.00.

Mallinckrodt PLC (NYSE:MNK) had its buy rating reissued by analysts at UBS AG. They currently have a $70.00 target price on the stock.

Maxim Integrated Products (NASDAQ:MXIM) had its buy rating reissued by analysts at Drexel Hamilton. The firm currently has a $52.00 target price on the stock.

Newell Brands (NYSE:NWL) had its hold rating reissued by analysts at Oppenheimer Holdings, Inc.. Oppenheimer Holdings, Inc. currently has a $50.00 target price on the stock.

Pennsylvania Real Estate Investment Trust (NYSE:PEI) had its hold rating reiterated by analysts at Boenning Scattergood.

Proofpoint (NASDAQ:PFPT) had its buy rating reissued by analysts at Evercore ISI. The firm currently has a $105.00 price target on the stock.

Dave & Buster’s Entertainment (NASDAQ:PLAY) had its buy rating reissued by analysts at Maxim Group. The firm currently has a $78.00 price target on the stock.

Pluristem Therapeutics (NASDAQ:PSTI) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $3.50 target price on the stock.

Portola Pharmaceuticals (NASDAQ:PTLA) had its buy rating reissued by analysts at Oppenheimer Holdings, Inc.. The firm currently has a $80.00 target price on the stock.

Sarepta Therapeutics (NASDAQ:SRPT) had its outperform rating reaffirmed by analysts at Robert W. Baird. They currently have a $101.00 price target on the stock.

Sarepta Therapeutics (NASDAQ:SRPT) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $75.00 target price on the stock.

Sunoco (NYSE:SUN) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a $35.00 price target on the stock, up from their previous price target of $32.00.

Thomson Reuters Corp (TSE:TRI) (NYSE:TRI) was upgraded by analysts at TD Securities from a hold rating to a buy rating. They currently have C$65.00 target price on the stock.

Verastem (NASDAQ:VSTM) had its buy rating reissued by analysts at Oppenheimer Holdings, Inc..

Westlake Chemical Corporation (NYSE:WLK) had its buy rating reiterated by analysts at SunTrust Banks, Inc.. SunTrust Banks, Inc. currently has a $86.00 price target on the stock.

Western Copper and Gold (NYSE:WRN) (TSE:WRN) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $2.25 target price on the stock.